D. Green and K. Lechner, A survey of 215 non-hemophilic patients with inhibitors to factor VIII, Thromb Haemost, vol.45, issue.3, pp.200-203, 1981.

J. Delgado, V. Jimenez-yuste, F. Hernandez-navarro, and A. Villar, Acquired Haemophilia: Review and Meta-Analysis Focused on Therapy and Prognostic Factors, British Journal of Haematology, vol.60, issue.1
DOI : 10.1046/j.1365-2257.2000.00316.x

P. Collins, S. Hirsch, and T. Baglin, Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation, Blood, vol.109, issue.5, pp.1870-1877, 2007.
DOI : 10.1182/blood-2006-06-029850

J. Saint-remy, S. Lacroix-desmazes, and J. Oldenburg, Inhibitors in haemophilia: pathophysiology, Haemophilia, vol.82, issue.s4, pp.146-151, 2004.
DOI : 10.1046/j.1365-2516.2001.00510.x

B. Wootla, S. Dasgupta, and J. Dimitrov, Factor VIII Hydrolysis Mediated by Anti-Factor VIII Autoantibodies in Acquired Hemophilia, The Journal of Immunology, vol.180, issue.11, pp.7714-7720, 2008.
DOI : 10.4049/jimmunol.180.11.7714

O. Castro, L. Farber, and L. Clyne, Circulating Anticoagulants Against Factors IX and XI in Systemic Lupus Erythematosus, Annals of Internal Medicine, vol.77, issue.4, pp.543-548, 1972.
DOI : 10.7326/0003-4819-77-4-543

D. Kyriakou, M. Alexandrakis, and F. Passam, Acquired inhibitors to coagulation factors in patients with gastrointestinal diseases, European Journal of Gastroenterology & Hepatology, vol.14, issue.12, pp.1383-1387, 2002.
DOI : 10.1097/00042737-200212000-00016

R. Largo, P. Sigg, A. Von-felten, and P. Straub, Acquired Factor-IX Inhibitor in a Nonhaemophilic Patient with Autoimmune Disease, British Journal of Haematology, vol.29, issue.1, pp.129-140, 1974.
DOI : 10.1097/00005792-196105000-00002

S. Ozsoylu and F. Ozer, Acquired Factor IX Deficiency, Acta Haematologica, vol.50, issue.5, pp.305-314, 1973.
DOI : 10.1159/000208364

H. Roberts, Acquired inhibitors to factor IX, N Engl J Med, vol.283, issue.10, pp.543-544, 1970.

J. Gouyon, F. Seiller, X. Deries, A. M. Lorenzini, J. Devilliers et al., Inhibitors of factors VIII and IX in a child with Henoch-Schonlein syndrome, Am J Pediatr Hematol Oncol, vol.7, issue.4, pp.376-377, 1985.

C. Reussi, R. Altman, J. Rouvier, and R. Maino, Combined factor VIII and IX inhibitors in a girl, Thromb Diath Haemorrh, vol.16, issue.3, pp.549-558, 1966.

H. Levesque, J. Borg, and J. Goudemand, Suivi ??volutif des??h??mophilies acquises: ??tude SACHA. ?? propos de??82??cas, La Revue de M??decine Interne, vol.27, issue.3, pp.298-299, 2006.
DOI : 10.1016/j.revmed.2006.10.028

C. Kasper, L. Aledort, and R. Counts, A more uniform measurement of factor VIII inhibitors, Thromb Diath Haemorrh, vol.34, pp.869-872, 1975.

S. Lacroix-desmazes, J. Bayry, and N. Misra, The Prevalence of Proteolytic Antibodies against Factor VIII in Hemophilia A, New England Journal of Medicine, vol.346, issue.9, pp.662-667, 2002.
DOI : 10.1056/NEJMoa011979

F. Olson, C. Hunt, F. Szoka, W. Vail, and D. Papahadjopoulos, Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.557, issue.1, pp.9-23, 1979.
DOI : 10.1016/0005-2736(79)90085-3

P. Fraker, J. Speck, and . Jr, Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril, Biochemical and Biophysical Research Communications, vol.80, issue.4, pp.849-857, 1978.
DOI : 10.1016/0006-291X(78)91322-0

B. Wootla, A. Mahendra, and J. Dimitrov, Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia, FEBS Letters, vol.106, issue.15, pp.2565-2572, 2009.
DOI : 10.1016/j.febslet.2009.07.009

URL : https://hal.archives-ouvertes.fr/hal-00409603

O. Christophe, P. Lenting, and G. Cherel, Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B, Blood, vol.98, issue.5, pp.1416-1423, 2001.
DOI : 10.1182/blood.V98.5.1416

C. Kessler, Acquired factor VIII autoantibody inhibitors: current concepts and potential therapeutic strategies for the future, Haematologica, vol.85, pp.57-61, 2000.

C. Refino, J. Himber, and L. Burcklen, A human antibody that binds to the gamma-carboxyglutamic acid domain of factor IX is a potent antithrombotic in vivo, Thromb Haemost, vol.82, issue.3, pp.1188-1195, 1999.

F. Scheiflinger, M. Dockal, J. Rosing, and R. Kerschbaumer, Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies, Journal of Thrombosis and Haemostasis, vol.96, issue.Suppl. 1, pp.315-322, 2008.
DOI : 10.1111/j.1538-7836.2008.02868.x

S. Butenas, T. Orfeo, M. Gissel, K. Brummel, and K. Mann, The Significance of Circulating Factor IXa in Blood, Journal of Biological Chemistry, vol.279, issue.22, pp.22875-22882, 2004.
DOI : 10.1074/jbc.M400531200

A. Takaki, D. Enfield, and A. Thompson, Cleavage and inactivation of Factor IX by granulocyte elastase., Journal of Clinical Investigation, vol.72, issue.5, pp.1706-1715, 1983.
DOI : 10.1172/JCI111130

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC370459

J. Samis, E. Kam, M. Nesheim, and A. Giles, Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function, Blood, vol.92, issue.4, pp.1287-1296, 1998.

J. Samis, G. Ramsey, J. Walker, M. Nesheim, and A. Giles, Proteolytic processing of human coagulation factor IX by plasmin, Blood, vol.95, issue.3, pp.943-951, 2000.

K. Bauer, B. Kass, H. Ten-cate, J. Hawiger, and R. Rosenberg, Factor IX is activated in vivo by the tissue factor mechanism, Blood, vol.76, issue.4, pp.731-736, 1990.

S. Lacroix-desmazes, A. Moreau, and . Sooryanarayana, Catalytic activity of antibodies against factor VIII in patients with hemophilia A, Nature Medicine, vol.5, issue.9, pp.1044-1047, 1999.
DOI : 10.1038/12483

S. Lacroix-desmazes, B. Wootla, and S. Dasgupta, Catalytic IgG from Patients with Hemophilia A Inactivate Therapeutic Factor VIII, The Journal of Immunology, vol.177, issue.2, pp.1355-1363, 2006.
DOI : 10.4049/jimmunol.177.2.1355

URL : http://eprints.iisc.ernet.in/16948/1/1.pdf

S. Paul, D. Volle, C. Beach, D. Johnson, M. Powell et al., Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody, Science, vol.244, issue.4909, pp.1158-1162, 1989.
DOI : 10.1126/science.2727702

N. Ponomarenko, O. Durova, and I. Vorobiev, Catalytic antibodies in clinical and experimental pathology: human and mouse models, Journal of Immunological Methods, vol.269, issue.1-2, pp.197-211, 2002.
DOI : 10.1016/S0022-1759(02)00324-1

N. Ponomarenko, O. Durova, and I. Vorobiev, Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen, Proceedings of the National Academy of Sciences, vol.356, issue.6364, pp.281-286, 2006.
DOI : 10.1038/356063a0

URL : https://hal.archives-ouvertes.fr/hal-00071187

A. Belogurov, . Jr, I. Kurkova, and A. Friboulet, Recognition and Degradation of Myelin Basic Protein Peptides by Serum Autoantibodies: Novel Biomarker for Multiple Sclerosis, The Journal of Immunology, vol.180, issue.2, pp.1258-1267, 2008.
DOI : 10.4049/jimmunol.180.2.1258

URL : https://hal.archives-ouvertes.fr/hal-00202308

L. Li, S. Paul, S. Tyutyulkova, M. Kazatchkine, and S. Kaveri, Catalytic activity of anti-thyroglobulin antibodies, J Immunol, vol.154, pp.3328-3332, 1995.

S. Lacroix-desmazes, J. Bayry, and S. Kaveri, High levels of catalytic antibodies correlate with favorable outcome in sepsis, Proceedings of the National Academy of Sciences, vol.344, issue.10, pp.4109-4113, 2005.
DOI : 10.1056/NEJM200103083441001

B. Wootla, A. Nicoletti, and N. Patey, Hydrolysis of Coagulation Factors by Circulating IgG Is Associated with a Reduced Risk for Chronic Allograft Nephropathy in Renal Transplanted Patients, The Journal of Immunology, vol.180, issue.12, pp.8455-8460, 2008.
DOI : 10.4049/jimmunol.180.12.8455

URL : https://hal.archives-ouvertes.fr/hal-00284906

L. Li, S. Paul, S. Tyutyulkova, M. D. Kazatchkine, and S. Kaveri, Catalytic activity of anti-thyroglobulin antibodies, J Immunol, vol.154, pp.3328-3332, 1995.

M. V. Govorun, B. Serebryakova, P. Avalle, A. Tornatore, H. C. Karavanov et al., Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen, Proc Natl Acad Sci, vol.103, pp.281-286, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00071187

S. V. Mohanty and . Kaveri, The prevalence of proteolytic antibodies against factor VIII in hemophilia A, N Engl J Med, vol.346, pp.662-667, 2002.

D. V. Semenov, T. G. Kanyshkova, Y. Y. Kit, D. Y. Khlimankov, A. M. Akimzhanov et al., Human breast milk immunoglobulins G hydrolyze nucleotides, Biochemistry (Mosc), vol.63, pp.935-943, 1998.

Y. Edmundson, S. Nishiyama, and . Paul, Ontogeny of proteolytic immunity: IgM serine proteases, J Biol Chem, vol.279, pp.14024-14032, 2004.

C. E. Charpentier, J. P. Luyt, V. Mira, M. D. Nagaraja, J. F. Kazatchkine et al., High levels of catalytic antibodies correlate with favorable outcome in sepsis, Proc Natl Acad Sci, vol.102, pp.4109-4113, 2005.

V. Kaveri and S. Lacroix-desmazes, Proteolytic antibodies activate factor IX in patients with acquired hemophilia, Blood, vol.117, pp.2257-2264, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00568179

S. V. Friboulet, S. Kaveri, O. Lacroix-desmazes, and . Thaunat, Hydrolysis of coagulation factors by circulating IgG is associated with a reduced risk for chronic allograft nephropathy in renal transplanted patients, J Immunol, vol.180, pp.8455-8460, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00284906

L. Pauling, Molecular Architecture and Biological Reactions, Chemical & Engineering News, vol.24, issue.10, pp.1375-1377, 1946.
DOI : 10.1021/cen-v024n010.p1375

S. Pollack, J. Jacobs, and P. Schultz, Selective chemical catalysis by an antibody, Science, vol.234, issue.4783, p.1570, 1986.
DOI : 10.1126/science.3787262

A. Tramontano, K. Janda, and R. Lerner, Catalytic antibodies, Science, vol.234, issue.4783, p.1566, 1986.
DOI : 10.1126/science.3787261

S. Paul, S. Planque, Y. Zhou, H. Taguchi, G. Bhatia et al., Specific HIV gp120-cleaving Antibodies Induced by Covalently Reactive Analog of gp120, Journal of Biological Chemistry, vol.278, issue.22, pp.20429-20435, 2003.
DOI : 10.1074/jbc.M300870200

B. Avalle, D. Thomas, and A. Friboulet, Functional mimicry: elicitation of a monoclonal anti-idiotypic antibody hydrolizing beta-lactams, Faseb J, vol.12, issue.11, pp.1055-1060, 1998.

S. Lacroix-desmazes, J. Bayry, N. Misra, M. Horn, S. Villard et al., The Prevalence of Proteolytic Antibodies against Factor VIII in Hemophilia A, New England Journal of Medicine, vol.346, issue.9, pp.662-667, 2002.
DOI : 10.1056/NEJMoa011979

S. Lacroix-desmazes, A. Moreau, . Sooryanarayana, C. Bonnemain, N. Stieltjes et al., Catalytic activity of antibodies against factor VIII in patients with hemophilia A, Nature Medicine, vol.5, issue.9, pp.1044-1047, 1999.
DOI : 10.1038/12483

L. Li, S. Paul, S. Tyutyulkova, M. Kazatchkine, and S. Kaveri, Catalytic activity of antithyroglobulin antibodies, J Immunol, vol.154, pp.3328-3332, 1995.

S. Paul, D. Volle, C. Beach, D. Johnson, M. Powell et al., Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody, Science, vol.244, issue.4909, pp.1158-1162, 1989.
DOI : 10.1126/science.2727702

A. Belogurov, . Jr, A. Kozyr, N. Ponomarenko, and A. Gabibov, Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde, BioEssays, vol.97, issue.11, pp.1161-1171, 2009.
DOI : 10.1002/bies.200900020

G. Nevinsky, T. Kanyshkova, D. Semenov, A. Vlassov, A. Gal-'vita et al., Secretory Immunoglobulin A from Healthy Human Mothers' Milk Catalyzes Nucleic Acid Hydrolysis, Applied Biochemistry and Biotechnology, vol.83, issue.1-3, pp.115-129, 2000.
DOI : 10.1385/ABAB:83:1-3:115

S. Planque, Y. Bangale, X. Song, S. Karle, H. Taguchi et al., Ontogeny of Proteolytic Immunity: IgM SERINE PROTEASES, Journal of Biological Chemistry, vol.279, issue.14, pp.14024-14032, 2004.
DOI : 10.1074/jbc.M312152200

Y. Mitsuda, S. Planque, M. Hara, R. Kyle, H. Taguchi et al., Naturally occurring catalytic antibodies: evidence for preferred development of the catalytic function in IgA class antibodies, Molecular Biotechnology, vol.78, issue.2, pp.113-122, 2007.
DOI : 10.1007/s12033-007-0003-7

S. Paul, L. Li, R. Kalaga, P. Wilkins-stevens, F. Stevens et al., Natural Catalytic Antibodies: Peptide-hydrolyzing Activities of Bence Jones Proteins and VL Fragment, Journal of Biological Chemistry, vol.270, issue.25
DOI : 10.1074/jbc.270.25.15257

H. Kohler and S. Paul, Superantibody activities: new players in innate and adaptive immune responses, Immunology Today, vol.19, issue.5, pp.221-226, 1998.
DOI : 10.1016/S0167-5699(97)01234-6

A. L. Notkins, Polyreactivity of antibody molecules, Trends in Immunology, vol.25, issue.4, pp.174-179, 2004.
DOI : 10.1016/j.it.2004.02.004

Z. H. Zhou, A. G. Tzioufas, and A. L. Notkins, Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells, Journal of Autoimmunity, vol.29, issue.4, pp.219-228, 2007.
DOI : 10.1016/j.jaut.2007.07.015

T. Tiller, M. Tsuiji, S. Yurasov, K. Velinzon, M. C. Nussenzweig et al., Autoreactivity in Human IgG+ Memory B Cells, Immunity, vol.26, issue.2, pp.205-213, 2007.
DOI : 10.1016/j.immuni.2007.01.009

J. Benckert, N. Schmolka, C. Kreschel, M. J. Zoller, A. Sturm et al., The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific, Journal of Clinical Investigation, vol.121, issue.5, pp.1946-1955, 2011.
DOI : 10.1172/JCI44447DS1

G. J. Wedemayer, P. A. Patten, L. H. Wang, P. G. Schultz, and R. C. Stevens, Structural Insights into the Evolution of an Antibody Combining Site, Science, vol.276, issue.5319, pp.1665-1669, 1997.
DOI : 10.1126/science.276.5319.1665

V. Manivel, N. C. Sahoo, D. M. Salunke, and K. V. Rao, Maturation of an Antibody Response Is Governed by Modulations in Flexibility of the Antigen-Combining Site, Immunity, vol.13, issue.5, pp.611-620, 2000.
DOI : 10.1016/S1074-7613(00)00061-3

R. Jimenez, G. Salazar, J. Yin, T. Joo, R. et al., Protein dynamics and the immunological evolution of molecular recognition, Proceedings of the National Academy of Sciences, vol.6, issue.4, pp.3803-3808, 2004.
DOI : 10.1016/S1367-5931(02)00341-1

R. Jimenez, G. Salazar, K. K. Baldridge, R. , and F. E. , Flexibility and molecular recognition in the immune system, Proceedings of the National Academy of Sciences, vol.91, issue.5, pp.92-97, 2003.
DOI : 10.1562/0031-8655(1998)067<0500:SPOFIS>2.3.CO;2

L. C. James and D. S. Tawfik, Conformational diversity and protein evolution ??? a 60-year-old hypothesis revisited, Trends in Biochemical Sciences, vol.28, issue.7, pp.361-368, 2003.
DOI : 10.1016/S0968-0004(03)00135-X

H. N. Eisen and A. K. Chakraborty, Evolving concepts of specificity in immune reactions, Proceedings of the National Academy of Sciences, vol.2, issue.8, p.22373, 2010.
DOI : 10.1038/90650

D. K. Sethi, A. Agarwal, V. Manivel, K. V. Rao, and D. M. Salunke, Differential Epitope Positioning within the Germline Antibody Paratope Enhances Promiscuity in the Primary Immune Response, Immunity, vol.24, issue.4, pp.429-438, 2006.
DOI : 10.1016/j.immuni.2006.02.010

A. F. Ochsenbein, T. Fehr, C. Lutz, M. Suter, F. Brombacher et al., Control of Early Viral and Bacterial Distribution and Disease by Natural Antibodies, Science, vol.286, issue.5447, pp.2156-2159, 1999.
DOI : 10.1126/science.286.5447.2156

Z. H. Zhou, Y. Zhang, Y. F. Hu, L. M. Wahl, J. O. Cisar et al., The Broad Antibacterial Activity of the Natural Antibody Repertoire Is Due to Polyreactive Antibodies, Cell Host & Microbe, vol.1, issue.1, pp.51-61, 2007.
DOI : 10.1016/j.chom.2007.01.002

H. Mouquet, J. F. Scheid, M. J. Zoller, M. Krogsgaard, R. G. Ott et al., Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation, Nature, vol.35, issue.7315, pp.591-595, 2010.
DOI : 10.1038/nature09385

B. F. Haynes, J. Fleming, E. W. St-clair, H. Katinger, G. Stiegler et al., Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies, Science, vol.308, issue.5730, pp.1906-1908, 2005.
DOI : 10.1126/science.1111781

R. Diskin, P. M. Marcovecchio, and P. J. Bjorkman, Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity, Nature Structural & Molecular Biology, vol.276, issue.5, pp.608-613, 2010.
DOI : 10.1038/nprot.2007.406

P. Grabar, Hypothesis. Auto-antibodies and immunological theories: An analytical review, Clinical Immunology and Immunopathology, vol.4, issue.4, pp.453-466, 1975.
DOI : 10.1016/0090-1229(75)90087-2

K. B. Elkon and G. J. Silverman, Naturally Occurring Autoantibodies to Apoptotic Cells, Adv Exp Med Biol, vol.750, pp.14-26, 2012.
DOI : 10.1007/978-1-4614-3461-0_2

H. U. Lutz, Homeostatic roles of naturally occurring antibodies: An overview, Journal of Autoimmunity, vol.29, issue.4, pp.287-294, 2007.
DOI : 10.1016/j.jaut.2007.07.007

J. Cabiedes, A. R. Cabral, and D. And-alarcon-segovia, Hidden anti-phospholipid antibodies in normal human sera circulate as immune complexes whose antigen can be removed by heat, acid, hypermolar buffers or phospholipase treatments, European Journal of Immunology, vol.2, issue.7, pp.2108-2114, 1998.
DOI : 10.1002/(SICI)1521-4141(199807)28:07<2108::AID-IMMU2108>3.0.CO;2-R

M. J. Mcmahon, O. Kennedy, and R. , Polyreactivity as an acquired artefact, rather than a physiologic property, of antibodies: evidence that monoreactive antibodies may gain the ability to bind to multiple antigens after exposure to low pH, Journal of Immunological Methods, vol.241, issue.1-2, pp.1-10, 2000.
DOI : 10.1016/S0022-1759(00)00196-4

J. P. Bouvet, D. Stahl, S. Rose, C. P. Quan, M. D. Kazatchkine et al., Induction of Natural Autoantibody Activity Following Treatment of Human Immunoglobulin with Dissociating Agents, Journal of Autoimmunity, vol.16, issue.2, pp.163-172, 2001.
DOI : 10.1006/jaut.2000.0472

I. K. Djoumerska-alexieva, J. D. Dimitrov, E. N. Voynova, S. Lacroix-desmazes, S. V. Kaveri et al., Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis, FEBS Journal, vol.420, issue.14, pp.3039-3050, 2010.
DOI : 10.1111/j.1742-4658.2010.07714.x

S. Lacroix-desmazes, L. Mouthon, A. Coutinho, and M. D. Kazatchkine, Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens, European Journal of Immunology, vol.13, issue.9, pp.2598-2604, 1995.
DOI : 10.1002/eji.1830250929

J. A. Mcintyre, The appearance and disappearance of antiphospholipid autoantibodies subsequent to oxidation???reduction reactions, Thrombosis Research, vol.114, issue.5-6, pp.579-587, 2004.
DOI : 10.1016/j.thromres.2004.08.008

J. A. Mcintyre, D. R. Wagenknecht, and W. P. Faulk, Autoantibodies unmasked by redox reactions, Journal of Autoimmunity, vol.24, issue.4, pp.311-317, 2005.
DOI : 10.1016/j.jaut.2005.03.005

J. A. Mcintyre, D. R. Wagenknecht, and W. P. Faulk, Redox-reactive autoantibodies: Detection and physiological relevance, Autoimmunity Reviews, vol.5, issue.1, pp.76-83, 2006.
DOI : 10.1016/j.autrev.2005.07.009

J. D. Dimitrov, N. D. Ivanovska, S. Lacroix-desmazes, V. R. Doltchinkova, S. V. Kaveri et al., Ferrous Ions and Reactive Oxygen Species Increase Antigen-binding and Anti-inflammatory Activities of Immunoglobulin G, Journal of Biological Chemistry, vol.281, issue.1, pp.439-446, 2006.
DOI : 10.1074/jbc.M509190200

J. D. Dimitrov, L. T. Roumenina, V. R. Doltchinkova, N. M. Mihaylova, S. Lacroix-desmazes et al., Antibodies Use Heme as a Cofactor to Extend Their Pathogen Elimination Activity and to Acquire New Effector Functions, Journal of Biological Chemistry, vol.282, issue.37, pp.26696-26706, 2007.
DOI : 10.1074/jbc.M702751200

N. M. Mihaylova, J. D. Dimitrov, I. K. Djoumerska-alexieva, and T. L. Vassilev, Inflammation-induced enhancement of IgG immunoreactivity, Inflammation Research, vol.57, issue.1, pp.1-3, 2008.
DOI : 10.1007/s00011-007-6213-4

J. Omersel, I. Jurgec, S. Cucnik, T. Kveder, B. Rozman et al., Autoimmune and proinflammatory activity of oxidized immunoglobulins, Autoimmunity Reviews, vol.7, issue.7, pp.523-529, 2008.
DOI : 10.1016/j.autrev.2008.04.005

I. K. Djoumerska-alexieva, J. D. Dimitrov, J. Nacheva, S. V. Kaveri, and T. L. Vassilev, Protein destabilizing agents induce polyreactivity and enhanced immunomodulatory activity in IVIg preparations, Autoimmunity, vol.57, issue.4, pp.365-367, 2009.
DOI : 10.1056/NEJMra993360

J. Omersel, I. Avbersek-luznik, P. A. Grabnar, T. Kveder, B. Rozman et al., Autoimmune reactivity of IgM acquired after oxidation, Redox Report, vol.38, issue.8, pp.248-256, 2011.
DOI : 10.1016/j.bbrc.2010.06.073

URL : https://repozitorij.uni-lj.si/Dokument.php?id=41750

M. Torres and A. Casadevall, The immunoglobulin constant region contributes to affinity and specificity, Trends in Immunology, vol.29, issue.2, pp.91-97, 2008.
DOI : 10.1016/j.it.2007.11.004

A. Casadevall and A. Janda, Immunoglobulin isotype influences affinity and specificity, Proceedings of the National Academy of Sciences, vol.207, issue.11, pp.12272-12273, 2012.
DOI : 10.1084/jem.20100995

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412040

F. Fais, F. Ghiotto, S. Hashimoto, B. Sellars, A. Valetto et al., Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors., Journal of Clinical Investigation, vol.102, issue.8, pp.1515-1525, 1998.
DOI : 10.1172/JCI3009

F. Ghiotto, F. Fais, A. Valetto, E. Albesiano, S. Hashimoto et al., Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia, Journal of Clinical Investigation, vol.113, issue.7, pp.1008-1016, 2004.
DOI : 10.1172/JCI19399DS1

O. Pritsch, G. Hudry-clergeon, M. Buckle, Y. Petillot, J. P. Bouvet et al., Can immunoglobulin C(H)1 constant region domain modulate antigen binding affinity of antibodies?, Journal of Clinical Investigation, vol.98, issue.10, pp.2235-2243, 1996.
DOI : 10.1172/JCI119033

URL : https://hal.archives-ouvertes.fr/hal-00277598

M. Torres, N. Fernandez-fuentes, A. Fiser, and A. Casadevall, The Immunoglobulin Heavy Chain Constant Region Affects Kinetic and Thermodynamic Parameters of Antibody Variable Region Interactions with Antigen, Journal of Biological Chemistry, vol.282, issue.18, pp.13917-13927, 2007.
DOI : 10.1074/jbc.M700661200

G. Gololobov, H. C. Morse, A. Friboulet, S. P. Makker, A. G. Gabibov et al., Routes to covalent catalysis by reactive selection for nascent protein nucleophiles, J Am Chem Soc, vol.129, pp.16175-82, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00199879

H. Rosenblum and H. Amital, Anti-TNF therapy: Safety aspects of taking the risk, Autoimmunity Reviews, vol.10, issue.9, pp.563-571, 2011.
DOI : 10.1016/j.autrev.2011.04.010

G. Sapparapu, S. Planque, Y. Mitsuda, G. Mclean, Y. Nishiyama et al., Constant Domain-regulated Antibody Catalysis, Journal of Biological Chemistry, vol.287, issue.43, pp.36096-104
DOI : 10.1074/jbc.M112.401075

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476277

A. C. Satterthwait and W. P. Jencks, Mechanism of the aminolysis of acetate esters, Journal of the American Chemical Society, vol.96, issue.22, pp.7018-7049, 1974.
DOI : 10.1021/ja00829a034

D. V. Semenov, T. G. Kanyshkova, Y. Y. Kit, D. Y. Khlimankov, A. M. Akimzhanov et al., Human breast milk immunoglobulins G hydrolyze nucleotides, Biochemistry (Mosc), vol.63, pp.935-978, 1998.

D. Shabat, H. N. Lode, U. Pertl, R. A. Reisfeld, C. Rader et al., In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy, Proceedings of the National Academy of Sciences, vol.111, issue.3, pp.7528-7561, 2001.
DOI : 10.1038/bjc.1989.270

D. Shabat, C. Rader, B. List, R. A. Lerner, and C. F. Barbas, Multiple event activation of a generic prodrug trigger by antibody catalysis, Proceedings of the National Academy of Sciences, vol.36, issue.18, pp.6925-6955, 1999.
DOI : 10.1021/jm00070a013

A. M. Shuster, G. V. Gololobov, O. A. Kvashuk, A. E. Bogomolova, I. V. Smirnov et al., A catalytic antibody programmed for torsional activation of amide bond hydrolysis, Chemistry, vol.9, pp.3132-3142, 1992.

B. Avalle, D. Thomas, and A. Friboulet, Functional mimicry: elicitation of a monoclonal anti-idiotypic antibody hydrolyzing beta-lactams, FASEB J, vol.12, pp.1055-1060, 1998.

Y. Bangale, S. Karle, S. Planque, Y. X. Zhou, H. Taguchi et al., VIPase autoantibodies in Fas-defective mice and patients with autoimmune disease, The FASEB Journal, vol.17, issue.6, pp.628-635, 2003.
DOI : 10.1096/fj.02-0475com

G. J. Barrera, R. Portillo, A. Mijares, M. A. Rocafull, J. R. Del-castillo et al., Immunoglobulin A with protease activity secreted in human milk activates PAR-2 receptors, of intestinal epithelial cells HT-29, and promotes beta-defensin-2 expression, Immunology Letters, vol.123, issue.1, pp.52-59, 2009.
DOI : 10.1016/j.imlet.2009.02.001

A. J. Belogurov, A. Kozyr, N. Ponomarenko, and A. Gabibov, Catalytic antibodies: balancing between Dr. Jekyll and Mr. Hyde, BioEssays, vol.97, issue.11, pp.1161-1171, 2009.
DOI : 10.1002/bies.200900020

C. Berek and C. Milstein, Mutation Drift and Repertoire Shift in the Maturation of the Immune Response, Immunological Reviews, vol.81, issue.1, pp.23-41, 1987.
DOI : 10.1038/311727a0

X. Brochet, M. P. Lefranc, and V. Giudicelli, IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis, Nucleic Acids Research, vol.36, issue.Web Server, pp.503-508, 2008.
DOI : 10.1093/nar/gkn316

URL : https://hal.archives-ouvertes.fr/hal-00322389

L. Brooks, C. J. Suckling, and W. H. Stimson, Construction of a single-chain Fv from an antibody which catalyses a Diels Alder cycloaddition, Biochemical Society Transactions, vol.24, issue.2, p.313, 1996.
DOI : 10.1042/bst024313s

P. Casali and A. L. Notkins, CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire, Immunology Today, vol.10, issue.11, pp.364-368, 1989.
DOI : 10.1016/0167-5699(89)90268-5

J. B. Charbonnier, E. Carpenter, B. Gigant, B. Golinelli-pimpaneau, Z. Eshhar et al., Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies., Proceedings of the National Academy of Sciences, vol.92, issue.25, pp.11721-11725, 1995.
DOI : 10.1073/pnas.92.25.11721

E. W. Debler, R. Müller, D. Hilvert, and I. A. Wilson, An aspartate and a water molecule mediate efficient acid-base catalysis in a tailored antibody pocket, Proceedings of the National Academy of Sciences, vol.98, issue.18, pp.18539-18544, 2009.
DOI : 10.1073/pnas.181342398

D. Souza, L. J. Gigant, B. Knossow, M. Green, and B. S. , Remarkable Remote Chiral Recognition in a Reaction Mediated by a Catalytic Antibody, Journal of the American Chemical Society, vol.124, issue.10, pp.2114-2115, 2002.
DOI : 10.1021/ja0170504

O. M. Durova, I. I. Vorobiev, I. V. Smirnov, A. V. Reshetnyak, G. B. Telegin et al., Strategies for induction of catalytic antibodies toward HIV-1 glycoprotein gp120 in autoimmune prone mice, Molecular Immunology, vol.47, issue.1, pp.87-95, 2009.
DOI : 10.1016/j.molimm.2008.12.020

URL : https://hal.archives-ouvertes.fr/hal-00430173

F. Ehrenmann, Q. Kaas, and M. P. Lefranc, IMGT/3Dstructure-DB and IMGT/DomainGapAlign: a database and a tool for immunoglobulins or antibodies, T cell receptors, MHC, IgSF and MhcSF, Nucleic Acids Research, vol.38, issue.suppl_1, pp.301-307, 2010.
DOI : 10.1093/nar/gkp946

URL : http://doi.org/10.1093/nar/gkp946

F. Ehrenmann and M. P. Lefranc, IMGT/DomainGapAlign: IMGT standardized analysis of amino acid sequences of variable, constant, and groove domains, Cold Spring Harb Protoc, issue.6, pp.737-749, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00616462

S. Erhan and L. D. Greller, Do immunoglobulins have proteolytic activity?, Nature, vol.70, issue.5473, pp.353-355, 1974.
DOI : 10.1038/251353a0

K. Ganesh and M. S. Neuberger, The relationship between hypothesis and experiment in unveiling the mechanisms of antibody gene diversification, The FASEB Journal, vol.25, issue.4, pp.1123-1132, 2011.
DOI : 10.1096/fj.11-0402ufm

Q. S. Gao, M. Sun, S. Tyutyulkova, D. Webster, A. Rees et al., Molecular cloning of a proteolytic antibody light chain, J. Biol. Chem, vol.269, pp.32389-32393, 1994.

B. Gigant, J. B. Charbonnier, Z. Eshhar, B. S. Green, and M. Knossow, Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody, Journal of Molecular Biology, vol.284, issue.3, pp.741-750, 1998.
DOI : 10.1006/jmbi.1998.2198

B. Gigant, T. Tsumuraya, I. Fujii, and M. Knossow, Diverse structural solutions to catalysis in a family of antibodies, Structure, vol.7, issue.11, pp.1385-1393, 1999.
DOI : 10.1016/S0969-2126(00)80028-3

V. Giudicelli, X. Brochet, and M. P. Lefranc, IMGT/V-QUEST: IMGT Standardized Analysis of the Immunoglobulin (IG) and T Cell Receptor (TR) Nucleotide Sequences, Cold Spring Harbor Protocols, vol.2011, issue.6, pp.695-715, 2011.
DOI : 10.1101/pdb.prot5633

URL : https://hal.archives-ouvertes.fr/hal-00616475

B. Golinelli-pimpaneau, C. Lüthi, and P. Christen, Structural Basis for D-Amino Acid Transamination by the Pyridoxal 5'-Phosphate-dependent Catalytic Antibody 15A9, Journal of Biological Chemistry, vol.281, issue.33, pp.23969-23977, 2006.
DOI : 10.1074/jbc.M602184200

G. Gololobov, M. Sun, and S. Paul, Innate antibody catalysis, Molecular Immunology, vol.36, issue.18, pp.1215-1222, 1999.
DOI : 10.1016/S0161-5890(99)00141-8

E. Hifumi, K. Hatiuchi, T. Okuda, A. Nishizono, Y. Okamura et al., Specific degradation of H. pylori urease by a catalytic antibody light chain, FEBS Journal, vol.173, issue.17, pp.4497-4505, 2005.
DOI : 10.1038/88563

E. Hifumi, Y. Mitsuda, K. Ohara, and T. Uda, Targeted destruction of the HIV-1 coat protein gp41 by a catalytic antibody light chain, Journal of Immunological Methods, vol.269, issue.1-2, pp.283-298, 2002.
DOI : 10.1016/S0022-1759(02)00242-9

E. Hifumi, F. Morihara, K. Hatiuchi, T. Okuda, A. Nishizono et al., Catalytic Features and Eradication Ability of Antibody Light-chain UA15-L against Helicobacter pylori, Journal of Biological Chemistry, vol.283, issue.2, pp.899-907, 2008.
DOI : 10.1074/jbc.M705674200

E. Hifumi, Y. Yamada, and T. Uda, A catalytic antibody heavy chain HpU-2 degrading its epitope peptide and H. pylori urease, Immunology Letters, vol.103, issue.1, pp.68-74, 2006.
DOI : 10.1016/j.imlet.2005.10.016

P. G. Hoel, S. C. Port, and C. J. Stone, Introduction to Statistical Theory, 1971.

K. Hotta, H. Lange, D. J. Tantillo, K. N. Houk, D. Hilvert et al., Catalysis of decarboxylation by a preorganized heterogeneous microenvironment: crystal structures of abzyme 21D8, Journal of Molecular Biology, vol.302, issue.5, pp.1213-1225, 2000.
DOI : 10.1006/jmbi.2000.4503

M. Hugot, N. Bensel, M. Vogel, M. T. Reymond, B. Stadler et al., A structural basis for the activity of retro-Diels-Alder catalytic antibodies: Evidence for a catalytic aromatic residue, Proceedings of the National Academy of Sciences, vol.228, issue.1, pp.9674-9678, 2002.
DOI : 10.1016/0022-2836(92)90487-5

R. Kalaga, L. Li, J. R. O-'dell, and S. Paul, Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis, J. Immunol, vol.155, pp.2695-2702, 1995.

Y. R. Kim, J. S. Kim, S. H. Lee, W. R. Lee, J. N. Sohn et al., Heavy and Light Chain Variable Single Domains of an Anti-DNA Binding Antibody Hydrolyze Both Double- and Single-stranded DNAs without Sequence Specificity, Journal of Biological Chemistry, vol.281, issue.22, pp.15287-15295, 2006.
DOI : 10.1074/jbc.M600937200

Y. Y. Kit, D. V. Semenov, and G. A. Nevinsky, Phosphorylation of different human milk proteins by human catalytic secretory immunoglobulin A, IUBMB Life, vol.39, issue.3, pp.521-527, 1996.
DOI : 10.1080/15216549600201571

M. Lefranc, . Mh, and M. Igsf, IMGT Collier de Perles for the variable (V), constant (C), and groove (G) domains of IG, Cold Spring Harb. Protoc, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00616560

M. P. Lefranc, V. Giudicelli, C. Ginestoux, J. Jabado-michaloud, G. Folch et al., IMGT(R), the international ImMunoGeneTics information system(R), IMGT ® , the international ImMunoGeneTics information system ®, pp.1006-1012, 2009.
DOI : 10.1093/nar/gkn838

URL : https://hal.archives-ouvertes.fr/hal-00357158

M. P. Lefranc and G. Lefranc, The Immunoglobulin Facts Book, 2001.

M. Lefranc, C. Pommié, M. Ruiz, V. Giudicelli, E. Foulquier et al., IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains, Developmental & Comparative Immunology, vol.27, issue.1, pp.55-77, 2003.
DOI : 10.1016/S0145-305X(02)00039-3

R. A. Lerner, Rare antibodies from combinatorial libraries suggests an S.O.S. component of the human immunological repertoire, Molecular BioSystems, vol.103, issue.8, pp.1004-1012, 2011.
DOI : 10.1039/c0mb00310g

B. Ma and R. Nussinov, Enzyme dynamics point to stepwise conformational selection in catalysis, Current Opinion in Chemical Biology, vol.14, issue.5, pp.652-659, 2010.
DOI : 10.1016/j.cbpa.2010.08.012

K. M. Mckenzie, J. M. Mee, C. J. Rogers, M. S. Hixon, G. F. Kaufmann et al., Identification and Characterization of Single Chain Anti-cocaine Catalytic Antibodies, Journal of Molecular Biology, vol.365, issue.3, pp.722-731, 2007.
DOI : 10.1016/j.jmb.2006.10.031

Y. Mitsuda, E. Hifumi, K. Tsuruhata, H. Fujinami, N. Yamamoto et al., Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5, 2004.

M. Oda, N. Ito, T. Tsumuraya, K. Suzuki, M. Sakakura et al., Thermodynamic and Structural Basis for Transition-State Stabilization in Antibody-Catalyzed Hydrolysis, Journal of Molecular Biology, vol.369, issue.1, pp.198-209, 2007.
DOI : 10.1016/j.jmb.2007.03.023

P. A. Patten, N. S. Gray, P. L. Yang, C. B. Marks, G. J. Wedemayer et al., The Immunological Evolution of Catalysis, Science, vol.271, issue.5252, pp.1086-1091, 1996.
DOI : 10.1126/science.271.5252.1086

S. Paul, S. Karle, S. Planque, H. Taguchi, M. Salas et al., Naturally Occurring Proteolytic Antibodies: SELECTIVE IMMUNOGLOBULIN M-CATALYZED HYDROLYSIS OF HIV gp120, Journal of Biological Chemistry, vol.279, issue.38, pp.39611-39619, 2004.
DOI : 10.1074/jbc.M406719200

S. Paul, Y. Nishiyama, S. Planque, and H. Taguchi, Theory of proteolytic antibody occurrence, Immunology Letters, vol.103, issue.1, pp.8-16, 2006.
DOI : 10.1016/j.imlet.2005.10.003

S. Paul, A. Tramontano, G. Gololobov, Y. X. Zhou, H. Taguchi et al., Phosphonate Ester Probes for Proteolytic Antibodies, Journal of Biological Chemistry, vol.276, issue.30, pp.28314-28320, 2001.
DOI : 10.1074/jbc.M102530200

D. Pillet, M. Paon, I. I. Vorobiev, A. G. Gabibov, D. Thomas et al., Idiotypic network mimicry and antibody catalysis: lessons for the elicitation of efficient anti-idiotypic protease antibodies, Journal of Immunological Methods, vol.269, issue.1-2, pp.5-12, 2002.
DOI : 10.1016/S0022-1759(02)00221-1

URL : https://hal.archives-ouvertes.fr/hal-00087959

S. Planque, Y. Bangale, X. T. Song, S. Karle, H. Taguchi et al., Ontogeny of Proteolytic Immunity: IgM SERINE PROTEASES, Journal of Biological Chemistry, vol.279, issue.14, pp.14024-14032, 2004.
DOI : 10.1074/jbc.M312152200

S. J. Pollack, J. W. Jacobs, and P. G. Schultz, Selective chemical catalysis by an antibody, Science, vol.234, issue.4783, pp.1570-1573, 1986.
DOI : 10.1126/science.3787262

N. A. Ponomarenko, O. M. Durova, I. I. Vorobiev, E. S. Aleksandrova, G. B. Telegin et al., Catalytic antibodies in clinical and experimental pathology: human and mouse models, Journal of Immunological Methods, vol.269, issue.1-2, pp.197-211, 2002.
DOI : 10.1016/S0022-1759(02)00324-1

N. A. Ponomarenko, O. M. Durova, I. I. Vorobiev, A. A. Belugorov, I. N. Kurkova et al., Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen, Proc. Natl. Acad, 2006.
DOI : 10.1038/356063a0

URL : https://hal.archives-ouvertes.fr/hal-00071187

T. R. Poulsen, P. J. Meijer, A. Jensen, N. S. Nielsen, and P. S. Andersen, Kinetic, Affinity, and Diversity Limits of Human Polyclonal Antibody Responses against Tetanus Toxoid, The Journal of Immunology, vol.179, issue.6, pp.3841-3850, 2007.
DOI : 10.4049/jimmunol.179.6.3841

P. A. Ramsland, S. S. Terzyan, G. Cloud, C. R. Bourne, W. Farrugia et al., Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody, Biochemical Journal, vol.395, issue.3, pp.473-481, 2006.
DOI : 10.1042/BJ20051739

F. E. Romesberg, B. Spiller, P. G. Schultz, and R. C. Stevens, Immunological Origins of Binding and Catalysis in a Diels-Alderase Antibody, Science, vol.279, issue.5358, pp.1929-1933, 1998.
DOI : 10.1126/science.279.5358.1929

V. Sharma, W. Heriot, K. Trisler, and V. Smider, A Human Germ Line Antibody Light Chain with Hydrolytic Properties Associated with Multimerization Status, Journal of Biological Chemistry, vol.284, issue.48, pp.33079-33087, 2009.
DOI : 10.1074/jbc.M109.036087

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2785149

I. Smirnov, E. Carletti, I. Kurkova, F. Nachon, Y. Nicolet et al., Reactibodies generated by kinetic selection couple chemical reactivity with favorable protein dynamics, Proc. Natl. Acad. Sci. U.S.A, pp.15954-15959, 2011.
DOI : 10.1073/pnas.0907548106

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179052

J. Sun, N. Takahashi, H. Kakinuma, and Y. Nishi, Molecular Evolution of Catalytic Antibodies in Autoimmune Mice, The Journal of Immunology, vol.167, issue.10, pp.5775-5785, 2001.
DOI : 10.4049/jimmunol.167.10.5775

H. Taguchi, S. Planque, G. Sapparapu, S. Boivin, M. Hara et al., Exceptional Amyloid ?? Peptide Hydrolyzing Activity of Nonphysiological Immunoglobulin Variable Domain Scaffolds, Journal of Biological Chemistry, vol.283, issue.52, pp.36724-36733, 2008.
DOI : 10.1074/jbc.M806766200

F. Tanaka, H. Almer, R. A. Lerner, I. Barbas, and C. , Catalytic single-chain antibodies possessing ??-lactamase activity selected from a phage displayed combinatorial library using a mechanism-based inhibitor, Tetrahedron Letters, vol.40, issue.46, pp.8063-8066, 1999.
DOI : 10.1016/S0040-4039(99)01695-0

D. S. Tawfik, R. Chap, B. S. Green, M. Sela, and Z. Eshhar, Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?, Proc. Natl. Acad, 1995.
DOI : 10.1073/pnas.92.6.2145

M. M. Thayer, E. H. Olender, A. S. Arvai, C. K. Koike, I. L. Canestrelli et al., Structural Basis for Amide Hydrolysis Catalyzed by the 43C9 Antibody, Journal of Molecular Biology, vol.291, issue.2, pp.329-345, 1999.
DOI : 10.1006/jmbi.1999.2960

A. Tramontano, K. J. Janda, and R. Lerner, Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen., Proc. Natl. Acad, 1986.
DOI : 10.1073/pnas.83.18.6736

T. Uda and E. Hifumi, Super catalytic antibody and antigenase, Journal of Bioscience and Bioengineering, vol.97, issue.3, pp.143-152, 2004.
DOI : 10.1016/S1389-1723(04)70183-8

H. D. Ulrich, E. Mundorff, B. D. Santarsiero, E. M. Driggers, R. C. Stevens et al., The interplay between binding energy and catalysis in the evolution of a catalytic antibody, Nature, vol.389, pp.271-275, 1997.

S. Venkateshrao, J. Yin, A. A. Jarzecki, P. G. Schultz, and T. G. Spiro, Porphyrin Distortion during Affinity Maturation of a Ferrochelatase Antibody, Monitored by Resonance Raman Spectroscopy, Journal of the American Chemical Society, vol.126, issue.50, pp.16361-16367, 2004.
DOI : 10.1021/ja0465395

M. Wang, C. Rada, and M. S. Neuberger, Altering the spectrum of immunoglobulin V gene somatic hypermutation by modifying the active site of AID, The Journal of Experimental Medicine, vol.306, issue.1, pp.141-153, 2010.
DOI : 10.1074/jbc.M311616200

G. J. Wedemayer, P. A. Patten, L. H. Wang, P. G. Schultz, and R. C. Stevens, Structural Insights into the Evolution of an Antibody Combining Site, Science, vol.276, issue.5319, pp.1665-1669, 1997.
DOI : 10.1126/science.276.5319.1665

B. Wootla, O. D. Christophe, A. Mahendra, J. D. Dimitrov, Y. Repessé et al., Proteolytic antibodies activate factor IX in patients with acquired hemophilia, Blood, vol.117, issue.7, pp.2257-2264, 2011.
DOI : 10.1182/blood-2010-07-296103

URL : https://hal.archives-ouvertes.fr/hal-00568179

J. Xu, Q. Deng, J. Chen, K. N. Houk, J. Bartek et al., Evolution of Shape Complementarity and Catalytic Efficiency from a Primordial Antibody Template, Science, vol.286, issue.5448, pp.2345-2348, 1999.
DOI : 10.1126/science.286.5448.2345

Y. Xu, N. Yamamoto, and K. D. Janda, Catalytic Antibodies: Hapten Design Strategies and Screening Methods, ChemInform, vol.12, issue.6, pp.5247-5268, 2004.
DOI : 10.1002/chin.200506239

P. L. Yang and P. G. Schultz, Mutational analysis of the affinity maturation of antibody 48G7, Journal of Molecular Biology, vol.294, issue.5, pp.1191-1201, 1999.
DOI : 10.1006/jmbi.1999.3197

H. S. Zein, J. A. Teixeira-da-silva, and K. Miyatake, Structure???function analysis and molecular modeling of DNase catalytic antibodies, Immunology Letters, vol.129, issue.1, pp.13-22, 2010.
DOI : 10.1016/j.imlet.2010.01.004

H. S. Zein, J. A. Teixeira-da-silva, and K. Miyatake, Molecular analysis of multicatalytic monoclonal antibodies, Molecular Immunology, vol.47, issue.9, pp.1747-1756, 2010.
DOI : 10.1016/j.molimm.2010.02.024

L. Zheng, J. P. Goddard, U. Baumann, and J. L. Reymond, Expression Improvement and Mechanistic Study of the Retro-Diels-Alderase Catalytic Antibody 10F11 by Site-directed Mutagenesis, Journal of Molecular Biology, vol.341, issue.3, pp.807-814, 2004.
DOI : 10.1016/j.jmb.2004.06.014

G. W. Zhou, J. Guo, W. Huang, R. J. Fletterick, and T. S. Scanlan, Crystal structure of a catalytic antibody with a serine protease active site, Science, vol.265, issue.5175, pp.1059-1064, 1994.
DOI : 10.1126/science.8066444

Z. H. Zhou, A. G. Tzioufas, and A. L. Notkins, Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells, Journal of Autoimmunity, vol.29, issue.4, pp.219-228, 2007.
DOI : 10.1016/j.jaut.2007.07.015

X. Zhu, P. Wentworth-jr, A. D. Wentworth, A. Eschenmoser, R. A. Lerner et al., Probing the antibody-catalyzed water-oxidation pathway at atomic resolution, Proceedings of the National Academy of Sciences, vol.50, issue.Pt 6, pp.2247-2252, 2004.
DOI : 10.1107/S0907444994006396

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC356936

C. M. Kessler, Acquired factor VIII autoantibody inhibitors: current concepts and potential therapeutic strategies for the future, Haematologica, vol.85, pp.57-61, 2000.

A. D. Ma and D. Carrizosa, Acquired Factor VIII Inhibitors: Pathophysiology and Treatment, Hematology, vol.2006, issue.1, 2006.
DOI : 10.1182/asheducation-2006.1.432

C. A. Fulcher, S. De-graaf-mahoney, and T. S. Zimmerman, Factor VIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting, Blood, vol.69, issue.5, pp.1475-1480, 1987.

D. Scandella, H. Nakai, M. Felch, W. Mondorf, I. Scharrer et al., In Hemophilia A and Autoantibody Inhibitor Patients: The Factor VIII A2 Domain and Light Chain Are Most Immunogenic, Thrombosis Research, vol.101, issue.5, pp.377-385, 2001.
DOI : 10.1016/S0049-3848(00)00418-7

S. Shapiro, The Immunologic Character of Acquired Inhibitors of Antihemophilic Globulin (Factor VIII) and the Kinetics of Their Interaction with Factor VIII*, Journal of Clinical Investigation, vol.46, issue.2, pp.147-156, 1967.
DOI : 10.1172/JCI105517

S. Lacroix-desmazes, Catalytic activity of antibodies against factor VIII in patients with hemophilia A, Nature Medicine, vol.5, issue.9, pp.1044-1047, 1999.
DOI : 10.1038/12483

B. Wootla, Factor VIII Hydrolysis Mediated by Anti-Factor VIII Autoantibodies in Acquired Hemophilia, The Journal of Immunology, vol.180, issue.11, pp.7714-7720, 2008.
DOI : 10.4049/jimmunol.180.11.7714

S. Lacroix-desmazes, The Prevalence of Proteolytic Antibodies against Factor VIII in Hemophilia A, New England Journal of Medicine, vol.346, issue.9, pp.662-667, 2002.
DOI : 10.1056/NEJMoa011979

S. Lacroix-desmazes, Catalytic IgG from Patients with Hemophilia A Inactivate Therapeutic Factor VIII, The Journal of Immunology, vol.177, issue.2, pp.1355-1363, 2006.
DOI : 10.4049/jimmunol.177.2.1355

URL : http://eprints.iisc.ernet.in/16948/1/1.pdf

C. A. Fulcher, K. Lechner, and S. De-graaf-mahoney, Immunoblot analysis shows changes in FVIII inhibitor chain specificity in FVIII inhibitor patients over time, Blood, vol.72, pp.1348-1356, 1988.

S. Lacroix-desmazes, A. Moreau, A. Pashov, . Sooryanarayana, D. Stahl et al., Natural Antibodies to Factor VIII, Seminars in Thrombosis and Hemostasis, vol.26, issue.Number 02, pp.157-165, 2000.
DOI : 10.1055/s-2000-9818

G. Hu, D. Guo, N. S. Key, and B. M. Conti-fine, T cells specific for coagulation factor VIII in healthy subjects and haemophilia A patients, Thrombosis and Haemostasis, vol.97, pp.788-794, 2007.
DOI : 10.1160/TH06-09-0519

Q. S. Gao, M. Sun, S. Tyutyulkova, D. Webster, A. Rees et al., Molecular cloning of a proteolytic antibody light chain, J. Biol. Chem, vol.269, pp.32389-32393, 1994.

L. Li, S. Paul, S. Tyutyulkova, M. D. Kazatchkine, and S. Kaveri, Catalytic activity of anti-thyroglobulin antibodies, J. Immunol, vol.154, pp.3328-3332, 1995.

S. Paul, Characterization of thyroglobulin-directed and polyreactive catalytic antibodies in autoimmune disease, J. Immunol, vol.159, pp.1530-1536, 1997.

R. Kalaga, L. Li, J. R. O-'dell, and S. Paul, Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis, J. Immunol, vol.155, pp.2695-2702, 1995.

S. Lacroix-desmazes, High levels of catalytic antibodies correlate with favorable outcome in sepsis, Proc. Natl. Acad. Sci. USA, pp.4109-4113, 2005.
DOI : 10.1056/NEJM200103083441001

B. Wootla, Hydrolysis of Coagulation Factors by Circulating IgG Is Associated with a Reduced Risk for Chronic Allograft Nephropathy in Renal Transplanted Patients, The Journal of Immunology, vol.180, issue.12, pp.8455-8460, 2008.
DOI : 10.4049/jimmunol.180.12.8455

URL : https://hal.archives-ouvertes.fr/hal-00284906

W. C. Aird, The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome, Blood, vol.101, issue.10, pp.3765-3777, 2003.
DOI : 10.1182/blood-2002-06-1887

H. Holschermann, Hirudin Reduces Tissue Factor Expression and Attenuates Graft Arteriosclerosis in Rat Cardiac Allografts, Circulation, vol.102, issue.3, pp.357-363, 2000.
DOI : 10.1161/01.CIR.102.3.357

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.509.9820

H. Holschermann, In Situ Detection of Tissue Factor within the Coronary Intima in Rat Cardiac Allograft Vasculopathy, The American Journal of Pathology, vol.154, issue.1, pp.211-220, 1999.
DOI : 10.1016/S0002-9440(10)65267-4

M. H. Yen, G. Pilkington, R. C. Starling, N. B. Ratliff, P. M. Mccarthy et al., Increased Tissue Factor Expression Predicts Development of Cardiac Allograft Vasculopathy, Circulation, vol.106, issue.11, pp.1379-1383, 2002.
DOI : 10.1161/01.CIR.0000028588.73765.B4

L. Pauling, Nature of Forces between Large Molecules of Biological Interest, Nature, vol.161, issue.4097, pp.707-716, 1948.
DOI : 10.1038/161707a0

L. Pauling, Molecular Architecture and Biological Reactions, Chemical & Engineering News, vol.24, issue.10, pp.1375-1382, 1946.
DOI : 10.1021/cen-v024n010.p1375

W. Jencks, Catalysis in Chemistry and Enzymology, p.339, 1969.

A. Satterthwait and W. Jencks, Mechanism of the aminolysis of acetate esters, Journal of the American Chemical Society, vol.96, issue.22
DOI : 10.1021/ja00829a034

S. Pollack, J. Jacobs, and P. Schultz, Selective chemical catalysis by an antibody, Science, vol.234, issue.4783, p.343
DOI : 10.1126/science.3787262

A. Tramontano, K. Janda, and R. Lerner, Catalytic antibodies, Science, vol.234, issue.4783, pp.1566-345, 1986.
DOI : 10.1126/science.3787261

K. Janda, C. Shevlin, and R. Lerner, Antibody catalysis of a disfavored chemical transformation, Science, vol.259, issue.5094, pp.490-493, 1993.
DOI : 10.1126/science.8424171

L. Ding, Z. Liu, Z. Zhu, G. Luo, D. Zhao et al., Biochemical characterization of selenium-containing catalytic antibody as a cytosolic glutathione peroxidase mimic, Biochemical Journal, vol.332, issue.1, pp.251-256, 1998.
DOI : 10.1042/bj3320251

B. Iverson and R. Lerner, Sequence-specific peptide cleavage catalyzed by an anti- 368 body, Science, vol.243, pp.367-382, 1989.
DOI : 10.1126/science.2922606

P. Wirsching, J. Ashley, C. Lo, K. Janda, and R. Lerner, Reactive Immunization, Science, vol.270, issue.5243, pp.1775-1783, 1995.
DOI : 10.1126/science.270.5243.1775

T. Uda and E. Hifumi, Super catalytic antibody and antigenase, Journal of Bioscience and Bioengineering, vol.97, issue.3, 2004.
DOI : 10.1016/S1389-1723(04)70183-8

R. Algiman, M. Dietrich, G. Nydegger, U. Boieldieu, D. Sultan et al., Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals., Proceedings of the National Academy of Sciences of the United States of America, pp.3795-3799, 1992.
DOI : 10.1073/pnas.89.9.3795

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC525577

M. Arai, D. Scandella, and L. W. Hoyer, Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid., Journal of Clinical Investigation, vol.83, issue.6, 1978.
DOI : 10.1172/JCI114107

J. Astermark, J. Oldenburg, J. Carlson, A. Pavlova, K. Kavakli et al., Polymorphisms in the TNFA gene and the risk of inhibitor development in patients with hemophilia A, Blood, vol.108, issue.12, pp.3739-3745, 2006.
DOI : 10.1182/blood-2006-05-024711

J. Astermark, J. Oldenburg, A. Pavlova, E. Berntorp, and A. K. Lefvert, Polymorphisms in the IL10 but not in the IL1beta and IL4 genes are associated with inhibitor development in patients with hemophilia A, Blood, vol.107, issue.8, pp.3167-3172, 2006.
DOI : 10.1182/blood-2005-09-3918

J. Astermark, X. Wang, J. Oldenburg, E. Berntorp, and A. K. Lefvert, Polymorphisms in the CTLA-4 gene and inhibitor development in patients with severe hemophilia A, Journal of Thrombosis and Haemostasis, vol.11, issue.2, pp.263-265, 2007.
DOI : 10.1111/j.1538-7836.2007.02290.x

B. Avalle, D. Thomas, and A. Friboulet, Functional mimicry: elicitation of a monoclonal anti-idiotypic antibody hydrolizing beta-lactams, FASEB Journal, vol.12, pp.1055-1060, 1998.

A. G. Baranovskii, N. A. Ershova, V. N. Buneva, T. G. Kanyshkova, A. S. Mogelnitskii et al., Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis, Immunology Letters, vol.76, issue.3, pp.163-167, 2001.
DOI : 10.1016/S0165-2478(01)00185-7

L. N. Boggio, D. Green, E. N. Van-den-brink, E. A. Turenhout, J. Davies et al., Two amino acid sequences were identified that correspond to the N-terminus of factor IX (YNSG) and N-terminus of the heavy chain of factor IX (VVGG) IgG antibodies (Ab) from AHA patients specifically hydrolysed factor IX at the carboxy-terminal of the arginine residues (R-COOH), resulting in the release of the activation peptide. The release of the activation peptide yielded activated FIX Acquired hemophilia . Reviews in Clinical and Experimental Hematology Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain Multiple VH genes are used to assemble human antibodies directed toward the A3-C1 domains of factor VII, Fig 3. Activation of factor IX by purified IgG from a patient with AHA. IgG-mediated FIX degradation products classes of germline genes both derived from the V(H)1 family direct the formation of human antibodies that recognize distinct antigenic sites in the C2 domain of factor VIII. Blood, pp.389-404, 2000.

P. A. Castaldi and R. Penny, A macroglobulin with inhibitory activity against coagulation factor VIII, Blood, vol.35, pp.370-376, 1970.

P. W. Collins, S. Hirsch, T. P. Baglin, G. Dolan, J. Hanley et al., Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation, Blood, vol.109, issue.5, pp.1870-1877, 2007.
DOI : 10.1182/blood-2006-06-029850

S. Ehrenforth, W. Kreuz, I. Scharrer, R. Linde, M. Funk et al., Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs, The Lancet, vol.339, issue.8793, pp.594-598, 1992.
DOI : 10.1016/0140-6736(92)90874-3

P. J. Fay and D. Scandella, Human Inhibitor Antibodies Specific for the Factor VIII A2 Domain Disrupt the Interaction between the Subunit and Factor IXa, Journal of Biological Chemistry, vol.274, issue.42, pp.29826-29830, 1999.
DOI : 10.1074/jbc.274.42.29826

M. Franchini, Haemostasis and pregnancy, Thrombosis and Haemostasis, vol.95, pp.401-413, 2006.
DOI : 10.1160/TH05-11-0753

A. Friboulet, B. Avalle, H. Debat, and D. Thomas, A possible role of catalytic antibodies in metabolism, Immunology Today, vol.20, issue.10, pp.474-475, 1999.
DOI : 10.1016/S0167-5699(99)01528-5

C. A. Fulcher, S. De-graaf-mahoney, and T. S. Zimmerman, Factor VIII inhibitor IgG subclass and FVIII polypeptide specificity determined by immunoblotting, Blood, vol.69, pp.1475-1480, 1987.

M. S. Gawryl and L. W. Hoyer, Inactivation of factor VIII coagulant activity by two different types of human antibodies, Blood, vol.60, pp.1103-1109, 1982.

S. Gharagozlou, R. A. Sharifian, J. Khoshnoodi, K. Karimi, M. Milani et al., Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains, Thrombosis and Haemostasis, vol.101, pp.834-839, 2009.
DOI : 10.1160/TH08-08-0508

J. G. Gilles, S. C. Grailly, M. De-maeyer, M. G. Jacquemin, L. P. Vanderelst et al., In vivo neutralization of a C2 domain-specific human anti-Factor VIII inhibitor by an anti-idiotypic antibody, Blood, vol.103, issue.7, pp.2617-2623, 2004.
DOI : 10.1182/blood-2003-07-2207

H. I. Glueck and R. Hong, A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin., Journal of Clinical Investigation, vol.44, issue.11, pp.1866-1881, 1965.
DOI : 10.1172/JCI105294

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC289687

H. I. Glueck, M. C. Coots, M. Benson, F. E. Dwulet, and P. E. Hurtubise, A monoclonal immunoglobulin A (kappa) factor VIII:C inhibitor associated with primary amyloidosis: identification and characterization, Journal of Laboratory and Clinical Medicine, vol.113, pp.269-277, 1989.

D. Green and K. Lechner, A survey of 215 non-hemophilic patients with inhibitors to factor VIII, Thrombosis and Haemostasis, vol.45, pp.200-203, 1981.

P. A. Holme, F. Brosstad, and G. E. Tjonnfjord, Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies, Haemophilia, vol.70, issue.5, pp.510-515, 2005.
DOI : 10.1046/j.1365-2141.2000.02463.x

S. H. Hwang, J. A. Lim, H. C. Kim, H. W. Lee, and H. S. Kim, mutation in the Korean patients with acquired hemophilia A, The Korean Journal of Hematology, vol.46, issue.1, pp.49-51, 2011.
DOI : 10.5045/kjh.2011.46.1.49

L. Izadyar, A. Friboulet, M. H. Remy, A. Roseto, and D. Thomas, Monoclonal anti-idiotypic antibodies as functional internal images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity., Proceedings of the National Academy of Sciences of the United States of America, pp.8876-8880, 1993.
DOI : 10.1073/pnas.90.19.8876

M. G. Jacquemin, B. G. Desqueper, A. Benhida, L. Vander-elst, M. F. Hoylaerts et al., Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor, Blood, vol.92, pp.496-506, 1998.

M. Jacquemin, A. Benhida, K. Peerlinck, B. Desqueper, L. Vander-elst et al., A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von willebrand factor, Blood, vol.95, pp.156-163, 2000.

R. Kalaga, L. Li, J. R. O-'dell, and S. Paul, Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis, Journal of Immunology, vol.155, pp.2695-2702, 1995.

C. Kamate, P. J. Lenting, H. M. Van-den-berg, and T. Mutis, regulatory T cells may enhance or uncover factor VIII-specific T-cell responses in healthy individuals, Journal of Thrombosis and Haemostasis, vol.9, issue.3, pp.611-613, 2006.
DOI : 10.1111/j.1538-7836.2007.02336.x

M. D. Kazatchkine, S. Lacroix-desmazes, A. Moreau, and S. V. Kaveri, Idiotypic regulation of anti-factor VIII antibodies, Haematologica, vol.85, pp.97-99, 2000.

S. Lacroix-desmazes, A. Moreau, . Sooryanarayana, C. Bonnemain, N. Stieltjes et al., Catalytic activity of antibodies against factor VIII in patients with hemophilia A, Nature Medicine, vol.5, issue.9, pp.1044-1047, 1999.
DOI : 10.1038/12483

S. Lacroix-desmazes, A. Moreau, A. Pashov, . Sooryanarayana, D. Stahl et al., Natural Antibodies to Factor VIII, Seminars in Thrombosis and Hemostasis, vol.26, issue.Number 02, pp.157-165, 2000.
DOI : 10.1055/s-2000-9818

S. Lacroix-desmazes, J. Bayry, N. Misra, M. P. Horn, S. Villard et al., The Prevalence of Proteolytic Antibodies against Factor VIII in Hemophilia A, New England Journal of Medicine, vol.346, issue.9, pp.662-667, 2002.
DOI : 10.1056/NEJMoa011979

S. Lacroix-desmazes, J. Bayry, S. V. Kaveri, D. Hayon-sonsino, N. Thorenoor et al., High levels of catalytic antibodies correlate with favorable outcome in sepsis, Proceedings of the National Academy of Sciences of the United States of America, pp.4109-4113, 2005.
DOI : 10.1056/NEJM200103083441001

S. Lacroix-desmazes, B. Wootla, S. Delignat, S. Dasgupta, V. Nagaraja et al., Pathophysiology of catalytic antibodies, Immunology Letters, vol.103, issue.1, pp.3-7, 2006.
DOI : 10.1016/j.imlet.2005.10.007

URL : http://www.sciencedirect.com/science?_ob=ShoppingCartURL&_method=add&_eid=1-s2.0-S0165247805003226&originContentFamily=serial&_origin=article&_ts=1480648360&md5=26f55b466b50129a66e8fc7c24f6815f

S. Lacroix-desmazes, B. Wootla, S. Dasgupta, S. Delignat, J. Bayry et al., Catalytic IgG from Patients with Hemophilia A Inactivate Therapeutic Factor VIII, The Journal of Immunology, vol.177, issue.2, pp.1355-1363, 2006.
DOI : 10.4049/jimmunol.177.2.1355

URL : http://eprints.iisc.ernet.in/16948/1/1.pdf

L. Li, S. Paul, S. Tyutyulkova, M. D. Kazatchkine, and S. Kaveri, Catalytic activity of antithyroglobulin antibodies, Journal of Immunology, vol.154, pp.3328-3332, 1995.

A. Ligers, N. Teleshova, T. Masterman, W. X. Huang, and J. Hillert, CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms, Genes and Immunity, vol.2, issue.3, pp.145-152, 2001.
DOI : 10.1038/sj.gene.6363752

M. Maurer, S. Loserth, A. Kolb-maurer, A. Ponath, S. Wiese et al., A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1+49) alters T-cell activation, Immunogenetics, vol.54, pp.1-8, 2002.

S. L. Meeks, J. F. Healey, E. T. Parker, R. T. Barrow, and P. Lollar, Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation, Blood, vol.110, issue.13, pp.4234-4242, 2007.
DOI : 10.1182/blood-2007-06-096842

S. L. Meeks, J. F. Healey, E. T. Parker, R. T. Barrow, and P. Lollar, Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitors, Blood, vol.112, issue.4, pp.1151-1153, 2008.
DOI : 10.1182/blood-2008-01-132639

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515124

A. Moreau, S. Lacroix-desmazes, N. Stieltjes, E. Saenko, S. V. Kaveri et al., Antibodies to the FVIII light chain that neutralize FVIII procoagulant activity, are present in the plasma of non-responder patients with severe hemophilia A and healthy blood donors, Blood, vol.95, pp.3435-3441, 2000.

M. Nardi, S. Tomlinson, M. A. Greco, and S. Karpatkin, Complement-Independent, Peroxide-Induced Antibody Lysis of Platelets in HIV-1-Related Immune Thrombocytopenia, Cell, vol.106, issue.5, pp.551-561, 2001.
DOI : 10.1016/S0092-8674(01)00477-9

C. Nathan, IMMUNOLOGY: Catalytic Antibody Bridges Innate and Adaptive Immunity, Science, vol.298, issue.5601, pp.2143-2144, 2002.
DOI : 10.1126/science.1080005

S. Paul, D. J. Volle, C. M. Beach, D. R. Johnson, M. J. Powell et al., Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody, Science, vol.244, issue.4909, pp.1158-1162, 1989.
DOI : 10.1126/science.2727702

S. Paul, L. Li, R. Kalaga, P. Wilkins-stevens, F. J. Stevens et al., Natural Catalytic Antibodies: Peptide-hydrolyzing Activities of Bence Jones Proteins and VL Fragment, Journal of Biological Chemistry, vol.270, issue.25, pp.15257-15261, 1995.
DOI : 10.1074/jbc.270.25.15257

S. Paul, S. Planque, Y. X. Zhou, H. Taguchi, G. Bhatia et al., Specific HIV gp120-cleaving Antibodies Induced by Covalently Reactive Analog of gp120, Journal of Biological Chemistry, vol.278, issue.22, pp.20429-20435, 2003.
DOI : 10.1074/jbc.M300870200

L. Pauling, Molecular Architecture and Biological Reactions, Chemical & Engineering News, vol.24, issue.10, pp.1375-1377, 1946.
DOI : 10.1021/cen-v024n010.p1375

A. Pavlova, A. Diaz-lacava, H. Zeitler, J. Satoguina, B. Niemann et al., Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls, Haemophilia, vol.174, issue.12, pp.355-360, 2008.
DOI : 10.1111/j.0105-2896.2006.00419.x

A. Pavlova, D. Delev, S. Lacroix-desmazes, R. Schwaab, M. Mende et al., Impact of polymorphisms of the major histocompatibility complex class????II, interleukin-10, tumor necrosis factor-???? and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia????A, Journal of Thrombosis and Haemostasis, vol.14, issue.Suppl. 57, pp.2006-2015, 2009.
DOI : 10.1111/j.1538-7836.2009.03636.x

A. Pavlova, H. Zeitler, I. Scharrer, H. H. Brackmann, and J. Oldenburg, HLA genotype in patients with acquired haemophilia A, Haemophilia, vol.178, issue.Suppl. 12, pp.107-112, 2010.
DOI : 10.1111/j.1365-2516.2008.01976.x

K. Peerlinck, M. Jacquemin, J. Arnout, M. Hoylaerts, J. Gilles et al., Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in patients with mild hemophilia A, Blood, vol.93, pp.2267-2273, 1999.

S. Planque, Y. Bangale, X. T. Song, S. Karle, H. Taguchi et al., Ontogeny of Proteolytic Immunity: IgM SERINE PROTEASES, Journal of Biological Chemistry, vol.279, issue.14, pp.14024-14032, 2004.
DOI : 10.1074/jbc.M312152200

S. J. Pollack, J. W. Jacobs, and P. G. Schultz, Selective chemical catalysis by an antibody, Science, vol.234, issue.4783, p.1570, 1986.
DOI : 10.1126/science.3787262

N. A. Ponomarenko, O. M. Durova, I. I. Vorobiev, A. , E. S. Telegin et al., Catalytic antibodies in clinical and experimental pathology: human and mouse models, Journal of Immunological Methods, vol.269, issue.1-2, pp.197-211, 2002.
DOI : 10.1016/S0022-1759(02)00324-1

R. Prescott, H. Nakai, E. L. Saenko, I. Scharrer, I. M. Nilsson et al., The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups, Blood, vol.89, pp.3663-3671, 1997.

M. T. Reding, H. Wu, M. Krampf, D. K. Okita, B. M. Diethelm-okita et al., CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects, Thrombosis and Haemostasis, vol.82, pp.509-515, 1999.

M. Reding, H. Wu, M. Krampf, D. Okita, B. Diethelm-okita et al., Sensitization of CD4+ T cells to coagulation factor VIII: response in congenital and acquired hemophilia patients and in healthy subjects, Thrombosis and Haemostasis, vol.84, pp.643-652, 2000.

M. T. Reding, S. Lei, H. Lei, D. Green, J. Gill et al., Distribution of Th1- and Th2-induced Anti-factor VIII IgG Subclasses in congenital and acquired hemophilia patients, Thrombosis and Haemostasis, vol.88, pp.568-575, 2002.

M. T. Reding, D. K. Okita, B. M. Diethelm-okita, T. A. Anderson, and B. M. Conti-fine, Human CD4+ T-cell epitope repertoire on the C2 domain of coagulation factor VIII, Journal of Thrombosis and Haemostasis, vol.41, issue.Suppl. 1, pp.1777-1784, 2003.
DOI : 10.1046/j.1538-7836.2003.00251.x

M. T. Reding, D. K. Okita, B. M. Diethelm-okita, T. A. Anderson, and B. M. Conti-fine, Epitope repertoire of human CD4+ T cells on the A3 domain of coagulation factor VIII, Journal of Thrombosis and Haemostasis, vol.41, issue.8, pp.1385-1394, 2004.
DOI : 10.1093/nar/28.1.235

F. Rossi, Y. Sultan, and M. D. Kazatchkine, Anti-idiotypes against autoantibodies and alloantibodies to Factor VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins, Clinical and Experimental Immunology, vol.74, pp.311-316, 1988.

S. Sallah, N. P. Nguyen, J. M. Abdallah, and L. R. Hanrahan, Acquired hemophilia in patients with hematologic malignancies, Archives of Pathology and Laboratory Medicine, vol.124, pp.730-734, 2000.

C. De-la-salle, J. L. Charmantier, M. J. Baas, A. Schwartz, M. L. Wiesel et al., A deletion located in the 3¢ non translated part of the factor IX gene responsible for mild haemophilia B, Thrombosis and Haemostasis, vol.70, pp.370-371, 1993.

I. Sari, M. A. Erkurt, A. Ifran, K. Kaptan, and C. Beyan, Multiple myeloma presenting with acquired factor VIII inhibitor, International Journal of Hematology, vol.5, issue.2, pp.166-169, 2009.
DOI : 10.1007/s12185-009-0363-9

A. C. Satterthwait and W. P. Jencks, Mechanism of the aminolysis of acetate esters, Journal of the American Chemical Society, vol.96, issue.22, pp.7018-7031, 1974.
DOI : 10.1021/ja00829a034

D. Scandella, Epitope Specificity and Inactivation Mechanisms of Factor VIII Inhibitor Antibodies, Vox Sanguinis, vol.77, issue.Suppl. 1, pp.17-20, 1999.
DOI : 10.1159/000056708

H. Taguchi, S. Planque, G. Sapparapu, S. Boivin, M. Hara et al., Exceptional Amyloid ?? Peptide Hydrolyzing Activity of Nonphysiological Immunoglobulin Variable Domain Scaffolds, Journal of Biological Chemistry, vol.283, issue.52, pp.36724-36733, 2008.
DOI : 10.1074/jbc.M806766200

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2606003

N. R. Thomas, Hapten design for the generation of catalytic antibodies, Applied Biochemistry and Biotechnology, vol.8, issue.2-3, pp.345-372, 1994.
DOI : 10.1007/BF02787945

A. Tramontano, K. D. Janda, and R. A. Lerner, Catalytic antibodies, Science, vol.234, issue.4783, p.1566, 1986.
DOI : 10.1126/science.3787261

K. R. Viel, A. Ameri, T. C. Abshire, R. V. Iyer, R. G. Watts et al., Inhibitors of Factor VIII in Black Patients with Hemophilia, New England Journal of Medicine, vol.360, issue.16, pp.1618-1627, 2009.
DOI : 10.1056/NEJMoa075760

J. P. Wentworth, J. E. Mcdunn, A. D. Wentworth, C. Takeuchi, J. Nieva et al., Evidence for Antibody-Catalyzed Ozone Formation in Bacterial Killing and Inflammation, Science, vol.298, issue.5601, pp.2195-2199, 2002.
DOI : 10.1126/science.1077642

A. G. Wilson, J. A. Symons, T. L. Mcdowell, H. O. Mcdevitt, and G. W. Duff, Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation, Proceedings of the National Academy of Sciences of the United States of America, pp.3195-3199, 1997.

B. Wootla, S. Dasgupta, J. D. Dimitrov, J. Bayry, H. Levesque et al., Factor VIII Hydrolysis Mediated by Anti-Factor VIII Autoantibodies in Acquired Hemophilia, The Journal of Immunology, vol.180, issue.11, pp.7714-7720, 2008.
DOI : 10.4049/jimmunol.180.11.7714

B. Wootla, A. Mahendra, J. D. Dimitrov, A. Friboulet, A. Borel-derlon et al., Factor VIII-hydrolyzing IgG in acquired and congenital hemophilia, FEBS Letters, vol.106, issue.15, pp.2565-2572, 2009.
DOI : 10.1016/j.febslet.2009.07.009

URL : https://hal.archives-ouvertes.fr/hal-00409603

A. Borel-derlon, H. Levesque, J. Y. Borg, S. Andre, J. Bayry et al., Proteolytic antibodies activate factor IX in patients with acquired hemophilia, Blood, vol.117, pp.2257-2264, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00568179

T. T. Yee, A. Taher, K. J. Pasi, and C. A. Lee, A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period, Clinical and Laboratory Haematology, vol.31, issue.5, pp.275-278, 2000.
DOI : 10.1046/j.1365-2257.2000.00316.x

C. Zheng, D. Huang, L. Liu, R. Wu, S. Bergenbrant-glas et al., Interleukin-10 gene promoter polymorphisms in multiple myeloma, International Journal of Cancer, vol.160, issue.3, pp.184-188, 2001.
DOI : 10.1002/1097-0215(20010520)95:3<184::AID-IJC1031>3.0.CO;2-V